Study Stopped
No difference in outcome between the two groups
Signature Personalised Patient Care System With the Vanguard Knee System Study
Study on the Signature Personalised Patient Care System With the Vanguard Knee System
1 other identifier
interventional
325
9 countries
10
Brief Summary
The purpose of this study is to determine whether the percentage cases which have ideal mechanical axial alignment using the Vanguard total Knee implant with the Signature cutting blocks is higher than those without the use of Signature when measured immediately post-operatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2010
Longer than P75 for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 7, 2010
CompletedFirst Posted
Study publicly available on registry
March 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedSeptember 5, 2017
August 1, 2017
6.5 years
March 7, 2010
August 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mechanical Axial Alignment
Femoral and tibial component alignment, femoral and tibial rotational alignment, tibial posterior slope
Prior to Discharge: 0-2 weeks
Secondary Outcomes (1)
Clinical Outcome
6 months, 1 year
Study Arms (2)
Signature Knee Guide
EXPERIMENTALVanguard Knee System with Signature Knee Guide
Conventional Approach
ACTIVE COMPARATORVanguard Complete Knee System with Conventional Approach
Interventions
Use of Signature Knee Guide
Vanguard Knee System with conventional Instruments
Eligibility Criteria
You may qualify if:
- painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more of the knee compartments are involved
- correction of varus, valgus or posttraumatic deformity
- correction or revision of unsuccessful osteotomy (wedge cut from bone to improve alignment), or arthrodesis (fusion)
- need to obtain pain relief and improve function
- ability and willingness to follow instructions, including control of weight and activity level.
- a good nutritional state
- must have reached full skeletal maturity
- able and willing to undergo an MRI scan
You may not qualify if:
- infection
- sepsis
- osteomyelitis
- failure of a previous joint replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (12)
Insall Scott Kelly Institute
New York, New York, 10065, United States
Logan Hospital
Brisbane, Queensland, 4131, Australia
The Queen Elizabeth Hospital
Adelaide, South Australia, 5011, Australia
General Hospital Kreuzschwestern
Grieskirchen, Wels, Austria
The Orthopaedic Hospital Speising
Vienna, Austria
St Luc General Hospital
Brussels, Belgium
Aalborg University Hospital
Aalborg, Denmark
Medipole de Savoie
Chambéry, France
Amphia Ziekenhuis Breda
Breda, Netherlands
Torres Verdras Hospital
Torres Vedras, Lisbon District, Portugal
Danderyd Hospital
Stockholm, Sweden
Addenbrooke's Hospital
Cambridge, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Gordon Morrison, MBChB
The Queen Elizabeth Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2010
First Posted
March 24, 2010
Study Start
March 1, 2010
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
September 5, 2017
Record last verified: 2017-08